-
-
-
-
-
-
-
Onivyde® Regimen Demonstrated Statistically Significant Improvement in Overall Survival in Previously Untreated Metastatic Pancreatic Ductal Adenocarcinoma
-
-
-
-
-
-
-
Ipsen Strengthens Its Pre-clinical Oncology Pipeline With an Exclusive Worldwide-collaboration With BAKX Therapeutics Inc. for BKX-001, Targeting the Apoptosis Pathway
-
-
66,424 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

